What is the Prosigna test?

The Prosigna test is a DNA test that can distinguish between breast cancer patients who will benefit from chemotherapy and those who won't. The test measures the activity of 50 genes involved in breast cancer growth and calculates a patient's risk of the disease returning.

How does the Prosigna test work?

The Prosigna test works by analyzing a patient's DNA to determine their risk of breast cancer recurrence. The test can identify patients who will not benefit from chemotherapy and can be treated with hormone therapy alone.

What are the benefits of the Prosigna test?

The benefits of the Prosigna test include sparing patients from the harsh side effects of chemotherapy, improving their quality of life, and reducing the risk of unnecessary treatment. The test could also reduce healthcare costs and improve patient outcomes.

Is the Prosigna test available to all breast cancer patients?

The Prosigna test is not yet available to all breast cancer patients. However, the test is expected to become a standard tool in breast cancer treatment in the near future. Patients who are interested in the test should talk to their doctor or a healthcare professional.

What does the future hold for breast cancer research?

The future of breast cancer research is promising, with numerous advancements in the field of oncology. The development of the Prosigna test is just one example of the many breakthroughs that have been made in recent years. As research continues to evolve, we can expect to see even more effective treatments and therapies for breast cancer patients.

What is the Prosigna test?

The Prosigna test is a DNA test that can distinguish between breast cancer patients who will benefit from chemotherapy and those who won't. The test measures the activity of 50 genes involved in breast cancer growth and calculates a patient's risk of the disease returning.

How does the Prosigna test work?

The Prosigna test works by analyzing a patient's DNA to determine their risk of breast cancer recurrence. The test can identify patients who will not benefit from chemotherapy and can be treated with hormone therapy alone.

What are the benefits of the Prosigna test?

The benefits of the Prosigna test include sparing patients from the harsh side effects of chemotherapy, improving their quality of life, and reducing the risk of unnecessary treatment. The test could also reduce healthcare costs and improve patient outcomes.

Is the Prosigna test available to all breast cancer patients?

The Prosigna test is not yet available to all breast cancer patients. However, the test is expected to become a standard tool in breast cancer treatment in the near future. Patients who are interested in the test should talk to their doctor or a healthcare professional.

What does the future hold for breast cancer research?

The future of breast cancer research is promising, with numerous advancements in the field of oncology. The development of the Prosigna test is just one example of the many breakthroughs that have been made in recent years. As research continues to evolve, we can expect to see even more effective treatments and therapies for breast cancer patients.

Back to Trending News

Published: RecentDownload AppJoin Telegram

Breast Cancer Breakthrough: Millions Could Avoid Chemotherapy

#breast cancer#chemotherapy#dna test#cancer treatment#hormone therapy#uk

Download App Join Community

Raheem Sterling Arrested: What's Really Behind the Headlines

31 May 2026Read Article